Results 251 to 260 of about 1,187,841 (331)

Advancing Clinical Medicine with Raman Spectroscopy: Current Trends and Future Perspectives

open access: yesAdvanced Photonics Research, EarlyView.
Raman spectroscopy and microscopy may become excellent tools in clinical medicine, including hematology, oncology, infectious diseases, neurology, gastroenterology, reproductive medicine, rheumatology, and cardiovascular research. However, many challenges such as signal interference, standardization issues, and limited clinical application need to be ...
Jiří Bufka   +5 more
wiley   +1 more source

An Investigation of the <i>BRCA2</i> Met1915Thr Polymorphism in Azerbaijani Breast Cancer Patients. [PDF]

open access: yesMed Sci (Basel)
Safarzade Z   +8 more
europepmc   +1 more source

Exploring PANI/CBTS Nanofiber Composites as Supercapacitor Electrodes: Structure–Performance Correlation

open access: yesAdvanced Sustainable Systems, EarlyView.
This study explores the synergistic integration of polyaniline (PANI) nanofibers with a CBTS‐based composite for supercapacitor applications. Structural and chemical analyses confirm strong interactions between the components, enhancing electrical conductivity and stability.
Süleyman Gökhan Çolak   +5 more
wiley   +1 more source

The Role of MHC-II Diversity over Enclosure Design in Gut Microbiota Structuring of Captive Bengal Slow Lorises. [PDF]

open access: yesBiology (Basel)
Jiang R   +11 more
europepmc   +1 more source

Glucose Deprivation‐Induced Disulfidptosis via the SLC7A11‐INF2 Axis: Pan‐Cancer Prognostic Exploration and Therapeutic Validation

open access: yesAdvanced Science, EarlyView.
Glucose deprivation or GLUT1 inhibition induces disulfidptosis in SLC7A11high ovarian cancer cells by promoting cystine accumulation, NADPH/ATP depletion, and F‐actin disulfide formation. SLC7A11 interacts with INF2 to further increase H₂O₂ levels and impair mitochondrial fission, suppressing cell migration. Targeting the SLC7A11–INF2 axis represents a
Zhenyu Song   +9 more
wiley   +1 more source

XBP1s Mediates Cross‐resistance to Combination Treatment of CDK4/6 Inhibitors plus Endocrine Therapy in Breast Cancer

open access: yesAdvanced Science, EarlyView.
Elevated spliced form of X‐box–binding protein 1 (XBP1) correlates with unfavorable responses to endocrine therapy plus CDK4/6 inhibitors in HR+/HER2− advanced breast cancer. XBP1s facilitates cell proliferation and G1/S transition by transcriptionally activating SND1, thereby activating the E2F1 pathway.
Yuting Sang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy